Avita Medical, Inc. Common Stock (RCEL) is a publicly traded Healthcare sector company. As of July 14, 2026, RCEL trades at $4.04 with a market cap of $121.57M and a P/E ratio of -2.56. RCEL moved +1.65% today. Year to date, RCEL is +16.52%; over the trailing twelve months it is -31.63%. Its 52-week range spans $3.22 to $14.16. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces RCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover RCEL: 0 strong buy, 2 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $9.00.
| Metric | Value |
|---|---|
| Price | $4.04 |
| Market Cap | $121.57M |
| P/E Ratio | -2.56 |
| EPS | $-1.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.16 |
| 52-Week Low | $3.22 |
| Volume | 130.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $72.35M |
| Net Income | $-45.34M |
| Gross Margin | 81.36% |
3 analysts cover RCEL: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.